{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:42:36Z","timestamp":1780616556859,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.leukres.2016.11.001","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T19:00:20Z","timestamp":1478199620000},"page":"8-19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia"],"prefix":"10.1016","volume":"52","author":[{"given":"Antonieta","family":"Chavez-Gonzalez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Centeno-Llanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafne","family":"Moreno-Lorenzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel","family":"Sandoval-Esquivel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Aviles-Vazquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Elena","family":"Bravo-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Ruiz-Azuara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Ayala-Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Torres-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hector","family":"Mayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2016.11.001_bib0005","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic myeloid leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.leukres.2016.11.001_bib0010","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1126\/science.2408149","article-title":"Tyrosine kinase activity and transformation potency of bcr-abl oncogene products","volume":"274","author":"Lugo","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.leukres.2016.11.001_bib0015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.leukres.2005.06.028","article-title":"Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures","volume":"30","author":"Ch\u00e1vez-Gonz\u00e1lez","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2016.11.001_bib0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.arcmed.2003.09.005","article-title":"Hematopoietic stem cells in chronic myeloid leukemia","volume":"34","author":"Petzer","year":"2003","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.leukres.2016.11.001_bib0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1042\/CS20040336","article-title":"Chronic myeloid leukemia: stem cell derived but progenitor cell driven","volume":"109","author":"Marley","year":"2005","journal-title":"Clin. Sci."},{"key":"10.1016\/j.leukres.2016.11.001_bib0030","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1182\/blood.V94.6.2056","article-title":"Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia","volume":"94","author":"Holyoake","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.001_bib0035","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","article-title":"Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia","volume":"83","author":"Bedi","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.001_bib0040","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1073\/pnas.90.24.12015","article-title":"Unresponsiveness of primitive myeloid leukemia cells to macrophage inflammatory protein-1 alpha, an inhibitor of primitive normal hematopoietic cells","volume":"90","author":"Eaves","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.11.001_bib0045","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/328342a0","article-title":"Altered adhesive interactions with marrow stroma of hematopoietic progenitor cells in chronic myeloid leukemia","volume":"328","author":"Gordon","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2016.11.001_bib0050","doi-asserted-by":"crossref","first-page":"12804","DOI":"10.1073\/pnas.96.22.12804","article-title":"Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia","volume":"96","author":"Jiang","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.leukres.2016.11.001_bib0055","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.1998.00839.x","article-title":"Chronic myelogenous leukemia CD34+ cells exit G0\/G1 phases of cell cycle more rapidly than normal marrow CD34+ cells","volume":"102","author":"Traycoff","year":"1998","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2016.11.001_bib0060","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.leukres.2008.11.011","article-title":"In vitro biology of human myeloid leukemia","volume":"33","author":"Mayani","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2016.11.001_bib0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.001_bib0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.leukres.2016.11.001_bib0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5966\/sctm.2012-0159","article-title":"Kinase-independent mechanism of resistance of leukemia stem cells to tyrosine kinase inhibitors","volume":"3","author":"Ichim","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.leukres.2016.11.001_bib0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nrclinonc.2014.158","article-title":"Translational research in oncology\u201310 years of progress and future prospects","volume":"11","author":"Doroshow","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.leukres.2016.11.001_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/MBD.2001.19","article-title":"Knigth's move in the periodic table, from the copper to platinum, novel antitumor mixed chelate copper compounds, Casiopeinas, evaluated by an in vitro human and murine cancer cell line panel","volume":"8","author":"Gracia-Mora","year":"2001","journal-title":"Metal Based Drugs"},{"key":"10.1016\/j.leukres.2016.11.001_bib0090","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.2174\/092986710793213751","article-title":"Copper compounds in cancer chemotherapy","volume":"17","author":"Ruiz-Azuara","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.leukres.2016.11.001_bib0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jinorgbio.2008.10.006","article-title":"Antiproliferative activity and QSAR study of copper(II) mixed chelate [Cu(N-N)(acetylacetonato)]NO3 and [Cu(N-N)(glycinato)]NO3 complexes, (Casiopeinas)","volume":"103","author":"Bravo-G\u00f3mez","year":"2009","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.leukres.2016.11.001_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0887-2333(99)00082-X","article-title":"Induction of apoptosis by a novel copper based anticancer compound, Casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells","volume":"14","author":"De Vizcaya-Ruiz","year":"2000","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.leukres.2016.11.001_bib0105","first-page":"205","article-title":"Antineoplastic evaluation of two mixed chelate copper complexes (Casiopeinas\u00ae) in HCT-15 xenograft model","volume":"57","author":"Bravo-G\u00f3mez","year":"2013","journal-title":"J. Mex. Chem. Soc."},{"key":"10.1016\/j.leukres.2016.11.001_bib0110","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12253-008-9060-x","article-title":"Casiopeinas IIgly and IIIia induce apoptosis in medulloblatoma cells","volume":"14","author":"Mejia","year":"2008","journal-title":"Phatol. Oncol. Res."},{"key":"10.1016\/j.leukres.2016.11.001_bib0115","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10534-007-9089-4","article-title":"Casiopeina IIIia induces apoptosis in HCT-15 cells in vitro through caspase-dependente mechanisms and has antitumor effect in vivo","volume":"21","author":"Carvallo-Chaigneau","year":"2008","journal-title":"Biometals"},{"key":"10.1016\/j.leukres.2016.11.001_bib0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1593\/neo.04607","article-title":"CasII gly induces apoptosis in glioma C6 cells in vitro and in vivo through caspase-dependent and caspase-independent mechanisms","volume":"7","author":"Trejo-Solis","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.leukres.2016.11.001_bib0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.cbi.2006.12.002","article-title":"Mixed chelate copper complex, Casiopeina IIgly, binds and degrades nucleic acids: a mechanism of cytotoxicity","volume":"165","author":"Rivero-M\u00fcller","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.leukres.2016.11.001_bib0130","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.tiv.2011.05.008","article-title":"Genotoxicity of the copper antineoplastic coordination complexes Casiopeinas","volume":"25","author":"Serment-Guerrero","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.leukres.2016.11.001_bib0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jinorgbio.2012.01.010","article-title":"New achievements on biological aspects of copper complexes Casiopeinas\u00ae: interaction with DNA and proteins and anti-Trypanosoma cruzi activity","volume":"109","author":"Becco","year":"2012","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.leukres.2016.11.001_bib0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.tox.2009.12.010","article-title":"Casiopeina II gly-induced oxidative stress and mitocondrial dysfunction in human lung cancer A549 and H157 cells","volume":"268","author":"Kachadourian","year":"2010","journal-title":"Toxicology"},{"key":"10.1016\/j.leukres.2016.11.001_bib0145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinorgbio.2013.05.001","article-title":"Copper (II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212","volume":"126","author":"Guti\u00e9rrez","year":"2013","journal-title":"J. Inorg. Biochem."},{"key":"10.1016\/j.leukres.2016.11.001_bib0150","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.leukres.2003.11.005","article-title":"Severe functional alterations in vitro CD34+ cell subpopulations from patients with chronic myeloid leukemia","volume":"28","author":"Ch\u00e1vez-Gonz\u00e1lez","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2016.11.001_bib0155","unstructured":"Ruiz-Azuara, L., Procedimiento para la obtenci\u00f3n de complejos met\u00e1licos como agentes anticancer\u00edgenos. Tipo I. Patente de invenci\u00f3n en tr\u00e1mite, SECOFI 18801. P. I. 1990. Patente, 26\/01\/1994 no. 172967."},{"key":"10.1016\/j.leukres.2016.11.001_bib0160","unstructured":"Ruiz-Azuara, L., Process to obtain new mixed copper aminoacidate complexes from phenylatephenanthroline to be used as anticancerigenic agents. U.S. Patent application serial No. 07\/628,843., 21\/04\/1992 Number 5, 107, 005. Re35, 458, Feb. 18, 1997."},{"key":"10.1016\/j.leukres.2016.11.001_bib0165","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/jclinpath-2011-200569","article-title":"The neurofibromin 1 type I isoform predominance characterizes female population affected by stporadic breast cancer: preliminary data","volume":"65","author":"Marrero","year":"2012","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.leukres.2016.11.001_bib0170","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1182\/blood-2011-10-385658","article-title":"Rac2-MRC-cIII\u2013generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors","volume":"119","author":"Nieborowska-Skorska","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.001_bib0175","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.001_bib0180","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1182\/blood-2005-07-2947","article-title":"Dasatinib (BMS-354825) targets an earlier progenitor population than imatinib in primary CML but does not eliminate the quiescent fraction","volume":"107","author":"Copland","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.001_bib0185","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1182\/blood-2006-11-057521","article-title":"Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells","volume":"109","author":"Jorgensen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2016.11.001_bib0190","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.leukres.2016.11.001_bib0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.taap.2006.02.005","article-title":"Control of cellular proliferation by modulation of oxidative phosphorylation in human and rodent fast-growing tumor cells","volume":"215","author":"Rodr\u00edguez-Enriquez","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.leukres.2016.11.001_bib0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.critrevonc.2011.03.005","article-title":"Reactive oxygen species: are they important for haematopoiesis","volume":"81","author":"Sardina","year":"2012","journal-title":"Crit. Rev. Hematol."},{"key":"10.1016\/j.leukres.2016.11.001_bib0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","article-title":"Reactive oxygen species in cancer cells: live by the sword, die by the sword","volume":"10","author":"Schumacker","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2016.11.001_bib0210","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1158\/0008-5472.948.65.3","article-title":"Controlling tumor growth by modulating endogenous production of reactive oxygen species","volume":"65","author":"Laurent","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2016.11.001_bib0215","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2006.08.009","article-title":"Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by \u03b2-phenylethyl isothiocyanate","volume":"10","author":"Trachootham","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.leukres.2016.11.001_bib0220","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12011-014-0098-1","article-title":"Analysis of the DNA interaction of copper compounds belonging to the casiopeinas \u00ae antitumoral series","volume":"161","author":"Becco","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.leukres.2016.11.001_bib0225","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.tiv.2011.02.007","article-title":"Comparison between the antiproliferative effect and intracellular glutathione depletion induced by Casiopeina IIgly and cisplatin in murine melanoma B16 cells","volume":"25","author":"Alem\u00f3n-Medina","year":"2011","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.leukres.2016.11.001_bib0230","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1111\/bph.12183","article-title":"Targeting survival pathways in chronic myeloid leukaemia stem cells","volume":"169","author":"Sinclair","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.leukres.2016.11.001_bib0235","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1191\/096032700678815963","article-title":"Copper toxicity affects proliferation and viability of human hepatoma cells (HepG2 line)","volume":"19","author":"Aston","year":"2000","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.leukres.2016.11.001_bib0240","first-page":"1200","article-title":"Changes in expression of genes encoding antioxidant enzymes, heme oxygenase-1, Bcl-2, and Bcl-xl and in level of reactive oxygen species in tumor cells resistant to doxorubicin","volume":"71","author":"Kalinina","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.leukres.2016.11.001_bib0245","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nrd3801","article-title":"The determination and interpretation of the therapeutic index in drug development","volume":"11","author":"Muller","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.leukres.2016.11.001_bib0250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.canlet.2005.07.046","article-title":"Role of copper transporters in the uptake and efflux of platinum containing drugs","volume":"234","author":"Safaei","year":"2006","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.leukres.2016.11.001_bib0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1367-5931(02)00298-3","article-title":"Molecular mechanisms of copper uptake and distribution","volume":"6","author":"Puig","year":"2002","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.leukres.2016.11.001_bib0260","doi-asserted-by":"crossref","first-page":"15584","DOI":"10.3390\/molecules191015584","article-title":"Cellular transport mechanisms of cytotoxic metallodrugs: an overview beyond cisplatin","volume":"19","author":"Spreckelmeyer","year":"2014","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.leukres.2016.11.001_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-4608(99)00169-7","article-title":"Cytogenetics of the chronic myeloid leukemia-derived cell line K562: karyotype clarification by multicolor fluorescence in situ hybridization, comparative genomic hybridization, and locus-specific fluorescence in situ hybridization","volume":"118","author":"Gribble","year":"2000","journal-title":"Cancer Genet. Cytogenet."},{"issue":"4","key":"10.1016\/j.leukres.2016.11.001_bib0270","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0145-2126(00)00125-9","article-title":"Complete karyotype characterization of the K562 cell line by combined application of G-banding, multiplex-fluorescence in situ hybridization, fluorescence in situ hybridization, and comparative genomic hybridization","volume":"25","author":"Naumann","year":"2001","journal-title":"Leuk. Res."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616302417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212616302417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,12]],"date-time":"2022-07-12T06:16:50Z","timestamp":1657606610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212616302417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":54,"alternative-id":["S0145212616302417"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2016.11.001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Casiopeina III-Ea, a copper-containing small molecule, inhibits the in vitro growth of primitive hematopoietic cells from chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2016.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}